Journal
TRENDS IN IMMUNOLOGY
Volume 41, Issue 5, Pages 355-359Publisher
CELL PRESS
DOI: 10.1016/j.it.2020.03.007
Keywords
-
Categories
Funding
- National Institutes of Health (NIH) [R01AI137472, R01AI139092]
Ask authors/readers for more resources
Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
